128
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Uncoordinated regulation of atrial natriuretic factor and brain natriuretic peptide in lipopolysaccharide-treated Rats

&
Pages 140-149 | Received 27 Sep 2011, Accepted 20 Nov 2011, Published online: 06 Jan 2012

References

  • Awad AE, Kandalam V, Chakrabarti S, Wang X, Penninger JM, Davidge ST, Oudit GY, Kassiri Z. (2010). Tumor necrosis factor induces matrix metalloproteinases in cardiomyocytes and cardiofibroblasts differentially via superoxide production in a PI3Kgamma-dependent manner. Am J Physiol, Cell Physiol 298:C679–C692.
  • Bailly S, Ferrua B, Fay M, Gougerot-Pocidalo MA. (1990). Differential regulation of IL 6, IL 1 A, IL 1 beta and TNF alpha production in LPS-stimulated human monocytes: role of cyclic AMP. Cytokine 2:205–210.
  • Berni R, Savi M, Bocchi L, Delucchi F, Musso E, Chaponnier C, Gabbiani G, Clement S, Stilli D. (2009). Modulation of actin isoform expression before the transition from experimental compensated pressure-overload cardiac hypertrophy to decompensation. Am J Physiol Heart Circ Physiol 296:H1625–H1632.
  • Brueckmann M, Huhle G, Lang S, Haase KK, Bertsch T, Weiss C, Kaden JJ, Putensen C, Borggrefe M, Hoffmann U. (2005). Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis. Circulation 112:527–534.
  • Bruneau BG, de Bold AJ. (1994). Selective changes in natriuretic peptide and early response gene expression in isolated rat atria following stimulation by stretch or endothelin-1. Cardiovasc Res 28:1519–1525.
  • Burjonroppa SC, Tong AT, Xiao LC, Johnson MM, Yusuf SW, Lenihan DJ. (2007). Cancer patients with markedly elevated B-type natriuretic peptide may not have volume overload. Am J Clin Oncol 30:287–293.
  • Charpentier J, Luyt CE, Fulla Y, Vinsonneau C, Cariou A, Grabar S, Dhainaut JF, Mira JP, Chiche JD. (2004). Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 32:660–665.
  • Chua G, Kang-Hoe L. (2004). Marked elevations in N-terminal brain natriuretic peptide levels in septic shock. Crit Care 8:R248–R250.
  • Genth-Zotz S, von Haehling S, Bolger AP, Kalra PR, Wensel R, Coats AJ, Anker SD. (2002). Pathophysiologic quantities of endotoxin-induced tumor necrosis factor-alpha release in whole blood from patients with chronic heart failure. Am J Cardiol 90:1226–1230.
  • Ghadjar P, Rubie C, Aebersold DM, Keilholz U. (2009). The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer. Int J Cancer 125:741–745.
  • Hama N, Itoh H, Shirakami G, Nakagawa O, Suga S, Ogawa Y, Masuda I, Nakanishi K, Yoshimasa T, Hashimoto Y. (1995). Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 92:1558–1564.
  • Hartemink KJ, Groeneveld AB, de Groot MC, Strack van Schijndel RJ, van Kamp G, Thijs LG. (2001). alpha-atrial natriuretic peptide, cyclic guanosine monophosphate, and endothelin in plasma as markers of myocardial depression in human septic shock. Crit Care Med 29:80–87.
  • Hirata T, Osuga Y, Takamura M, Kodama A, Hirota Y, Koga K, Yoshino O, Harada M, Takemura Y, Yano T, Taketani Y. (2010). Recruitment of CCR6-expressing Th17 cells by CCL 20 secreted from IL-1 beta-, TNF-alpha-, and IL-17A-stimulated endometriotic stromal cells. Endocrinology 151:5468–5476.
  • Hoffmann U, Borggrefe M, Brueckmann M. (2006). New horizons: NT-proBNP for risk stratification of patients with shock in the intensive care unit. Crit Care 10:134.
  • Laxton RC, Hu Y, Duchene J, Zhang F, Zhang Z, Leung KY, Xiao Q, Scotland RS, Hodgkinson CP, Smith K, Willeit J, López-Otín C, Simpson IA, Kiechl S, Ahluwalia A, Xu Q, Ye S. (2009). A role of matrix metalloproteinase-8 in atherosclerosis. Circ Res 105:921–929.
  • Li YY, McTiernan CF, Feldman AM. (1999). Proinflammatory cytokines regulate tissue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardiac cells. Cardiovasc Res 42:162–172.
  • Ma KK, Ogawa T, de Bold AJ. (2004). Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase. J Mol Cell Cardiol 36:505–513.
  • Maeder M, Ammann P, Kiowski W, Rickli H. (2005). B-type natriuretic peptide in patients with sepsis and preserved left ventricular ejection fraction. Eur J Heart Fail 7:1164–1167.
  • Masters RG, Davies RA, Veinot JP, Hendry PJ, Smith SJ, de Bold AJ. (1999). Discoordinate modulation of natriuretic peptides during acute cardiac allograft rejection in humans. Circulation 100:287–291.
  • Meirovich YF, Veinot JP, de Bold ML, Haddad H, Davies RA, Masters RG, Hendry PJ, de Bold AJ. (2008). Relationship between natriuretic peptides and inflammation: proteomic evidence obtained during acute cellular cardiac allograft rejection in humans. J Heart Lung Transplant 27:31–37.
  • Morgenthaler NG, Struck J, Christ-Crain M, Bergmann A, Müller B. (2005). Pro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHE II score: an observational study. Crit Care 9:R37–R45.
  • Nikolaou NI, Goritsas C, Dede M, Paissios NP, Papavasileiou M, Rombola AT, Ferti A. (2007). Brain natriuretic peptide increases in septic patients without severe sepsis or shock. Eur J Intern Med 18:535–541.
  • Ogawa T, Linz W, Stevenson M, Bruneau BG, Kuroski de Bold ML, Chen JH, Eid H, Schölkens BA, de Bold AJ. (1996). Evidence for load-dependent and load-independent determinants of cardiac natriuretic peptide production. Circulation 93:2059–2067.
  • Ogawa T, Veinot JP, Kuroski de Bold ML, Georgalis T, de Bold AJ. (2008). Angiotensin II receptor antagonism reverts the selective cardiac BNP upregulation and secretion observed in myocarditis. Am J Physiol Heart Circ Physiol 294:H2596–H2603.
  • Ramos H, de Bold AJ. (2006). Gene expression, processing, and secretion of natriuretic peptides: physiologic and diagnostic implications. Heart Fail Clin 2:255–268.
  • Roch A. (2007). What does high NT-proBNP mean in septic shock patients? A part of the puzzle. Crit Care 11:122.
  • Shor R, Rozenman Y, Bolshinsky A, Harpaz D, Tilis Y, Matas Z, Fux A, Boaz M, Halabe A. (2006). BNP in septic patients without systolic myocardial dysfunction. Eur J Intern Med 17:536–540.
  • Smith BJ, Lerner MR, Bu SY, Lucas EA, Hanas JS, Lightfoot SA, Postier RG, Bronze MS, Brackett DJ. (2006). Systemic bone loss and induction of coronary vessel disease in a rat model of chronic inflammation. Bone 38:378–386.
  • Ueda S, Nishio K, Akai Y, Fukushima H, Ueyama T, Kawai Y, Masui K, Yoshioka A, Okuchi K. (2006). Prognostic value of increased plasma levels of brain natriuretic peptide in patients with septic shock. Shock 26:134–139.
  • Van Lint P, Wielockx B, Puimège L, Noël A, López-Otin C, Libert C. (2005). Resistance of collagenase-2 (matrix metalloproteinase-8)-deficient mice to TNF-induced lethal hepatitis. J Immunol 175:7642–7649.
  • Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, Vasan RS. (2004). Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350:655–663.
  • Weiss SJ, Peppin G, Ortiz X, Ragsdale C, Test ST. (1985). Oxidative autoactivation of latent collagenase by human neutrophils. Science 227:747–749.
  • Witthaut R, Busch C, Fraunberger P, Walli A, Seidel D, Pilz G, Stuttmann R, Speichermann N, Verner L, Werdan K. (2003). Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med 29:1696–1702.
  • Yucel T, Memis D, Karamanlioglu B, Süt N, Yuksel M. (2008). The prognostic value of atrial and brain natriuretic peptides, troponin I and C-reactive protein in patients with sepsis. Exp Clin Cardiol 13:183–188.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.